Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815908 antibody that binds the same epitope of alpha v beta 5 as bound by ALULA ; Pulmonary edema
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
10/19/2010US7815904 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction
10/19/2010CA2429544C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
10/19/2010CA2376031C Product from starfish
10/19/2010CA2365020C Ganp proteins
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2174559C Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010118243A2 Use of il-27 antagonists to treat lupus
10/14/2010WO2010118203A2 Endosialin binding molecules
10/14/2010WO2010117980A1 Dkk-1 antibodies
10/14/2010WO2010117325A1 New methods for treatment of inflammatory diseases
10/14/2010WO2010117059A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010WO2010117057A1 Method for treatment of blood tumor using anti-tim-3 antibody
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010116146A1 Anti-ecscr antibody and uses thereof
10/14/2010WO2010116123A1 Antibodies against il-17br
10/14/2010WO2010115998A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
10/14/2010WO2010115995A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
10/14/2010WO2010115874A1 Methods for the treatment and the diagnosis ofpulmonary arterial hypertension
10/14/2010WO2010115868A2 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
10/14/2010WO2010115843A2 Pharmaceutical composition
10/14/2010WO2010115786A1 Anti-il-23 immunoglobulins
10/14/2010WO2010115630A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010WO2010115629A2 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010WO2010115606A1 Human monoclonal antibody specific for lipopolysaccarides (lps) of serotype iats 01 of pseudomonas aeruginosa
10/14/2010WO2010115589A1 Trivalent, bispecific antibodies
10/14/2010WO2010115555A2 Antibodies against human tweak and uses thereof
10/14/2010WO2010115553A1 Bispecific anti-erbb-2/anti-c-met antibodies
10/14/2010WO2010115552A1 Bispecific anti-erbb-3/anti-c-met antibodies
10/14/2010WO2010115551A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010WO2010115261A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010WO2010080935A8 Monoclonal antibodies against pcbp-1 antigens, and uses therefor
10/14/2010WO2010078580A3 Immunotherapy for contact dermatitis using co-signal regulation
10/14/2010WO2010070346A3 BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Ra) - 836
10/14/2010WO2010065962A3 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
10/14/2010US20100263093 Transgenic plants and modulators for improved stress tolerance
10/14/2010US20100263061 Properdin Modulation of Alternative Pathway and Uses Thereof
10/14/2010US20100261887 Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosis
10/14/2010US20100261886 Protein purification by citrate precipitation
10/14/2010US20100261778 Tumor Suppressor Killin
10/14/2010US20100261647 Fusion proteins for delivery of erythropoietin to the cns
10/14/2010US20100261640 Soluble and membrane anchored forms of lassa virus subunit proteins
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261248 Pharmaceutical Composition Comprising An Immunoglobulin FC Region as a Carrier
10/14/2010US20100261217 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/14/2010US20100261210 Compositions and methods for diagnosing and treating prostate cancer
10/14/2010US20100261209 Biomarkers for liver diseases and method for using the same
10/14/2010US20100261200 Glycoprotein VI and Uses Thereof
10/14/2010US20100261199 Assay for the detection of phosphorylated PTH
10/14/2010US20100261195 Rapid antemortem detection of infectious agents
10/14/2010US20100261194 Neutrokine-alpha antibodies and methods of use thereof
10/14/2010US20100261190 Mammalian Genes; Related Reagents and Methods
10/14/2010US20100261169 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
10/14/2010US20100261026 Compositions comprising oriented, immobilized macromolecules and methods for their preparation
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260783 Antibody Specific Binding to A Beta Oligomer and the Use
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260776 Therapeutic method for reducing angiogenesis
10/14/2010US20100260775 Treatment Of Interstitial Cystitis
10/14/2010US20100260774 Netrin-1 Compositions and Methods of Use Thereof
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260770 Il-33 in inflammatory disease
10/14/2010US20100260769 Endosialin binding molecules
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260767 Composition and Method for Treating Inflammatory Disorders
10/14/2010US20100260765 Targeted binding agents directed to kdr and uses thereof - 035
10/14/2010US20100260763 Polypeptides, antibody variable domains and antagonists methods for
10/14/2010US20100260762 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
10/14/2010US20100260761 Antibodies specifically reactive with a tumor necrosis factor related ligand
10/14/2010US20100260759 Immunosuppressive polypeptides and nucleic acids
10/14/2010US20100260756 Antibodies and related molecules that bind to 161p2f10b proteins
10/14/2010US20100260754 Dkk-1 antibodies
10/14/2010US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
10/14/2010US20100260751 Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
10/14/2010US20100260748 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
10/14/2010US20100260742 Medicament and a method for regulation of the vascular tone
10/14/2010US20100260727 Method to amplify cardiac stem cells in vitro and in vivo
10/14/2010US20100260712 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260705 Products for altering il-33 activity and methods thereof
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2762187A1 New methods for treatment of inflammatory diseases
10/14/2010CA2758252A1 Dkk-1 antibodies
10/14/2010CA2758201A1 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010CA2758191A1 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
10/14/2010CA2758081A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o1 of pseudomonas aeruginosa
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2757931A1 Trivalent, bispecific antibodies
10/14/2010CA2757680A1 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
10/14/2010CA2757669A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010CA2757598A1 Diagnosis and treatment of gluten-induced autoimmune diseases
10/14/2010CA2757531A1 Bispecific anti-erbb-3/anti-c-met antibodies
10/14/2010CA2757426A1 Bispecific anti-erbb-2/anti-c-met antibodies
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 1494